Literature DB >> 16307860

A new approach to evaluate stability of amodiaquine and its metabolite in blood and plasma.

D Blessborn1, G Neamin, Y Bergqvist, N Lindegårdh.   

Abstract

A stability study for amodiaquine (AQ) and desethylamodiaquine (AQm) in whole blood and plasma is reported. AQ, AQm and chloroquine (CQ) were simultaneously analysed and the ratios AQ/CQ and AQm/CQ were used to ensure correct interpretation of the stability results. CQ was stable in whole blood and plasma at all tested temperatures enabling it to be a stability marker in stability studies. Simultaneous analysis of compounds, of which at least one is already known to be stable, permits a within sample ratio to be used as a stability indicator. The new approach significantly reduced bias when compared to the traditional approach. AQ and AQm were stable in plasma at -86 degrees C and -20 degrees C for 35 days, at 4 degrees C for 14 days and at 22 degrees C for 1 day. AQ and AQm were stable in blood at -86 degrees C and 4 degrees C for 35 days, at -20 degrees C and 22 degrees C for 7 days and at 37 degrees C for 1 day.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307860     DOI: 10.1016/j.jpba.2005.10.018

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  10 in total

1.  Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.

Authors:  Kimberly K Scarsi; Fatai A Fehintola; Qing Ma; Francesca T Aweeka; Kristin M Darin; Gene D Morse; Ibrahim Temitope Akinola; Waheed A Adedeji; Niklas Lindegardh; Joel Tarning; Oladosu Ojengbede; Isaac F Adewole; Babafemi Taiwo; Robert L Murphy; Olusegun O Akinyinka; Sunil Parikh
Journal:  J Antimicrob Chemother       Date:  2014-01-19       Impact factor: 5.790

2.  Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combination in areas of malaria endemicity.

Authors:  Olumuyiwa N Adedeji; Oluseye O Bolaji; Catherine O Falade; Odusoga A Osonuga; Olusegun G Ademowo
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

3.  Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques.

Authors:  Monica Vaccari; Claudio Fenizia; Zhong-Min Ma; Anna Hryniewicz; Adriano Boasso; Melvin N Doster; Christopher J Miller; Niklas Lindegardh; Joel Tarning; Alan L Landay; Gene M Shearer; Genoveffa Franchini
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-24       Impact factor: 2.205

4.  Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.

Authors:  Julia Mwesigwa; Sunil Parikh; Bryan McGee; Polina German; Troy Drysdale; Joan N Kalyango; Tamara D Clark; Grant Dorsey; Niklas Lindegardh; Anna Annerberg; Philip J Rosenthal; Moses R Kamya; Francesca Aweeka
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

5.  The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.

Authors:  Nguyen Xuan Thanh; Trieu Nguyen Trung; Nguyen Chinh Phong; Huynh Hong Quang; Bui Dai; G Dennis Shanks; Marina Chavchich; Michael D Edstein
Journal:  Malar J       Date:  2012-06-28       Impact factor: 2.979

6.  Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.

Authors:  Aung Pyae Phyo; Khin Maung Lwin; Ric N Price; Elizabeth A Ashley; Bruce Russell; Kanlaya Sriprawat; Niklas Lindegardh; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

7.  Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand.

Authors:  Marcus J Rijken; Machteld E Boel; Bruce Russell; Mallika Imwong; Mara L Leimanis; Aung Pyae Phyo; Atis Muehlenbachs; Niklas Lindegardh; Rose McGready; Laurent Rénia; Georges Snounou; Pratap Singhasivanon; François Nosten
Journal:  Malar J       Date:  2011-05-05       Impact factor: 2.979

8.  Pharmacokinetic interactions between primaquine and chloroquine.

Authors:  Sasithon Pukrittayakamee; Joel Tarning; Podjanee Jittamala; Prakaykaew Charunwatthana; Saranath Lawpoolsri; Sue J Lee; Warunee Hanpithakpong; Borimas Hanboonkunupakarn; Nicholas P J Day; Elizabeth A Ashley; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

9.  Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.

Authors:  Aurélia Souares; Patricia Moulin; Sophie Sarrassat; Marie-Paule Carlotti; Richard Lalou; Jean-Yves Le Hesran
Journal:  Malar J       Date:  2009-11-17       Impact factor: 2.979

10.  An HPLC method with diode array detector for the simultaneous quantification of chloroquine and desethylchloroquine in plasma and whole blood samples from Plasmodium vivax patients in Vietnam, using quinine as an internal standard.

Authors:  Toi Van Pham; Phuong Pham Nguyen; Tho Nguyen Duc Khanh; Nhien Nguyen Thanh Thuy; Ca Nguyen Thuy Nha; Thomas Pouplin; Jeremy Farrar; Guy E Thwaites; Hien Tran Tinh
Journal:  Biomed Chromatogr       Date:  2016-01-05       Impact factor: 1.902

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.